FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $47,938 | -93.4% | 10,071 | -85.9% | 0.03% | -93.1% |
| Q4 2022 | $721,647 | -55.8% | 71,521 | -1.7% | 0.48% | -52.4% |
| Q3 2022 | $1,631,000 | -4.3% | 72,766 | +5.8% | 1.01% | -3.4% |
| Q2 2022 | $1,705,000 | -23.9% | 68,793 | +19.0% | 1.04% | -13.4% |
| Q1 2022 | $2,241,000 | -21.2% | 57,808 | +18.9% | 1.20% | -20.5% |
| Q4 2021 | $2,844,000 | -1.8% | 48,603 | -0.5% | 1.52% | +13.6% |
| Q3 2021 | $2,895,000 | -32.9% | 48,838 | -1.7% | 1.33% | -38.2% |
| Q2 2021 | $4,312,000 | +11.9% | 49,685 | +6.3% | 2.16% | -2.1% |
| Q1 2021 | $3,855,000 | -2.5% | 46,755 | +7.6% | 2.21% | -19.7% |
| Q4 2020 | $3,953,000 | +132.4% | 43,468 | +13.6% | 2.75% | +114.5% |
| Q3 2020 | $1,701,000 | – | 38,263 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |